The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
Open accessAbstract
The specificity of T cell help for B cell activation and differentiation is maintained by the brief expression on the T cell surface, following T cell receptor-mediated triggering, of CD40 ligand (CD40L). Interaction of T helper (Th) cell CD40L with B cell CD40 induces B cell activation, cell surface expression of activation antigens, proliferation, and initiation of immunoglobulin isotype switch. We predicted that in patients with systemic lupus erythematosus (SLE), in whom Th cell-dependent production of autoantibodies results in immune complex-mediated tissue damage, CD40L expression might be augmented, prolonged, or abnormally regulated. Baseline expression of CD40L was increased in some SLE patients studied, when compared with control subjects. While Th cells from normal subjects (n = 14) and rheumatic disease control patients (n = 9) showed maximal expression of CD40L, after in vitro activation with phorbol myristate acetate (PMA) and ionomycin, at 6 h of culture with diminished levels observed at 24 and 48 h, Th cells from SLE patients (n = 19) maintained high level cell surface expression of CD40L through 24 and 48 h of culture. The prolonged expression of CD40L was functionally significant, as 24 h-activated SLE T cells, when cocultured with target B cells, induced greater B cell surface CD80 (B7-1) expression than did 24 h-activated normal T cells. These results document impaired regulation of CD40L expression in SLE T cells and identify an important potential target for therapy in this systemic autoimmune disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,692
The CD40 Antigen and Its Ligand
Banchereau, J., Bazan, F., Blanchard, D., Brière, F., Galizzi, J., van Kooten, C., Liu, Y. J., Rousset, F., & Saeland, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.881 · Cited by 1,263
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
Lehmann, P. V., Forsthuber, T., Miller, A., & Sercarz, E. E. (1992) · Nature · doi:10.1038/358155a0 · Cited by 1,186
CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome
Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K., et al. (1993) · Science · doi:10.1126/science.7679801 · Cited by 830
Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90668-g · Cited by 814
Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM
Korthäuer, U., Graf, D., Mages, H. W., Brière, F., Padayachee, M., Malcolm, S., Ugazio, A. G., Notarangelo, L. D., Levinsky, R. J., & Kroczek, R. A. (1993) · Nature · doi:10.1038/361539a0 · Cited by 721
CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM
DiSanto, J. P., Bonnefoy, J. Y., Gauchatt, J. F., Fischer, A., & Saint Basile, G. D. (1993) · Nature · doi:10.1038/361541a0 · Cited by 704
Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
Mohan, C., Adams, S., Stanik, V, & Datta, S. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1367 · Cited by 627
Humoral immune responses in CD40 ligand-deficient mice.
Renshaw, B. R., Fanslow, W. C., Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B. L., & Maliszewski, C. R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1889 · Cited by 536
Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05530.x · Cited by 511
Genetic and Structural Evidence for Antigen Selection of Anti-DNA Antibodies
Radic, M. Z. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.487 · Cited by 454
Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.
Spriggs, M. K., Armitage, R. J., Strockbine, L. D., Clifford, K. N., Macduff, B. M., Sato, T., Maliszewski, C. R., & Fanslow, W. C. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1543 · Cited by 388
Fuleihan, R., Ramesh, N., Loh, R., Jabara, H., Rosen, R. S., Chatila, T., Fu, S. M., Stamenkovic, I., & Geha, R. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2170 · Cited by 367
The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.
Roy, M., Waldschmidt, T., Aruffo, A., Ledbetter, J. A., & Noelle, R. J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2497 · Cited by 366
Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
Mohan, C., Shi, Y., Laman, J. D., & Datta, S. K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1470 · Cited by 364
Lederman, S., Yellin, M. J., Krichevsky, A., Belko, J., Lee, J. J., & Chess, L. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.4.1091 · Cited by 357
James, J. A., Gross, T., Scofield, R. H., & Harley, J. B. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.453 · Cited by 339
Tolerance, Danger and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.991 · Cited by 335
Burlingame, R. W., Boey, M. L., Starkebaum, G., & Rubin, R. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117305 · Cited by 300
Schattner, E. J., Elkon, K. B., Yoo, D. H., Tumang, J., Krammer, P. H., Crow, M. K., & Friedman, S. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1557 · Cited by 278
Self-citationThe lupus autoantigens and the pathogenesis of systemic lupus erythematosus
Hardin, J. A. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290401 · Cited by 255
Castigli, E., Alt, F. W., Davidson, L., Bottaro, A., Mizoguchi, E., Bhan, A. K., & Geha, R. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12135 · Cited by 238
The two-signal model of lymphocyte activation twenty-one years later
Bretscher, P. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90138-w · Cited by 229
Casamayor-Palleja, M., Khan, M., & MacLennan, I. C. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1293 · Cited by 226
Krishnan, C., & Kaplan, M. H. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105558 · Cited by 226
Roy, M., Aruffo, A., Ledbetter, J., Linsley, P., Kehry, M., & Noelle, R. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250243 · Cited by 214
Yellin, M. J., Sippel, K., Inghirami, G., Covey, L. R., Lee, J. J., Sinning, J., Clark, E. A., Chess, L., & Lederman, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.598 · Cited by 204
The CD40 ligand expressed by human B cells costimulates B cell responses.
Grammer, A. C., Bergman, M. C., Miura, Y., Fujita, K., Davis, L. S., & Lipsky, P. E. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.4996 · Cited by 195
Topfer, F., Gordon, T., & McCluskey, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.875 · Cited by 185
Durie, F. H., Aruffo, A., Ledbetter, J., Crassi, K. M., Green, W. R., Fast, L. D., & Noelle, R. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117453 · Cited by 180
Nonoyama, S., Hollenbaugh, D. L., Aruffo, A. A., Ledbetter, J. A., & Ochs, H. D. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.3.1097 · Cited by 155
Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.
Fuleihan, R., Ramesh, N., Horner, A., Ahern, D., Belshaw, P. J., Alberg, D. G., Stamenkovic, I., Harmon, W., & Geha, R. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117089 · Cited by 152
Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells.
Boussiotis, V. A., Nadler, L. M., Strominger, J. L., & Goldfeld, A. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7007 · Cited by 151
Yellin, M. J., Sinning, J. G., Covey, L. R., Sherman, W. H., Lee, J. J., Glickman-Nir, E., Sippel, K. C., Rogers, J., Cleary, A. M., Parker, M. A., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.2.666 · Cited by 143
Shapira, S. K., Vercelli, D., Jabara, H. H., Fu, S. M., & Geha, R. S. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.1.289 · Cited by 140
Lederman, S. M., Yellin, M. J., Cleary, A. M., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.5.2163 · Cited by 121
Human B cell precursors proliferate and express CD23 after CD40 ligation.
Saeland, S., Duvert, V., Moreau, I., & Banchereau, J. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.1.113 · Cited by 118
Fatenejad, S., Brooks, W. H., Schwartz, A., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.11.5523 · Cited by 73
Gharavi, A. E., Chu, J., & Elkon, K. B. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780311101 · Cited by 54
Crow, M. K., DelGiudice-Asch, G., Zehetbauer, J. B., Lawson, J. L., Brot, N., Weissbach, H., & Elkon, K. B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117328 · Cited by 49
Self-citationDirect T helper-B cell interactions induce an early B cell activation antigen.
Crow, M. K., Jover, J. Á., & Friedman, S. M. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.5.1760 · Cited by 36
Self-citation
Cited by
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
“Previous studies have reported an increase in CD154 expression on SLE T cells (Koshy et al., 1996).”
Backgroundvan Kooten, C., & Banchereau, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.2 · Cited by 1,404
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Self-citationThe CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
Boumpas, D. T., Furie, R., Manzi, S., Illei, G. G., Wallace, D. J., Balow, J. E., Vaishnaw, A., & on behalf of the BG9588 Lupus Nephritis Trial Group (2003) · Arthritis & Rheumatism · doi:10.1002/art.10856 · Cited by 618
Metadata
- Authors
- Koshy, M., Berger, D., & Crow, M. K.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-08-01
- Volume
- 98
- Issue
- 3
- Pages
- 826-837
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2052803753
- Cited by
- 359
- References
- 43
- FWCI
- 12.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.